Aarti Drugs Ltd
Aarti Drugs | 524348
Stock Performance
Ratios
About Company
- Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals
- The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million
- With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs
- Company also operates Pinnacle Life Science Private Limited, its wholly owned subsidiary focused on formulation development
- The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra
- It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary)
- Of the above subsidiaries, Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited are wholly owned subsidiaries
- The manufacturing units of the Company are GMP certified
- Their products include Active Pharmaceutical Ingredients (APIs), Steroids, Pharmaceutical Intermediates, and Specialty Chemicals, such as Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide
- In 1993, the company implemented the second phase of their backward integration project and set up facilities for glyoxal (the main raw material for imidazoles)
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Frequently Asked Questions
What is Share Price of Aarti Drugs Ltd?
The current share price of Aarti Drugs Ltd (Aarti Drugs) is ₹462.80. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Aarti Drugs Ltd?
The Price-to-Earnings (P/E) ratio of Aarti Drugs Ltd is 462.80. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Aarti Drugs Ltd?
Aarti Drugs Ltd has a 52-week high of ₹564.05 and a 52-week low of ₹312.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Aarti Drugs Ltd?
Aarti Drugs Ltd offers a dividend yield of 0.21%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Aarti Drugs Ltd?
The Earnings Per Share (EPS) of Aarti Drugs Ltd is ₹21.66. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Aarti Drugs Ltd?
Aarti Drugs Ltd has a Return on Equity (ROE) of 12.97%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
